Search Within

Population Sciences Research Program

Refine Results
Formats
  1. Journal Article (5542)
  2. Meeting Abstract (2325)
  3. Book Section (234)
  4. Conference Paper (48)
  5. Book Whole (18)
Groups
  1. Survivorship Research (3606)
  2. Epidemiology and Biostatistics (3327)
  3. Solid Tumor Oncology Division (2166)
  4. Surgery (1910)
  5. Psychiatry and Behavioral Sciences, Department of (1791)
  6. Biostatistics Service (1574)

More Groups

People
  1. Andrew Vickers (614)
  2. Kenneth Offit (602)
  3. Mark Robson (452)
  4. Steven Horwitz (406)
  5. William Breitbart (392)
  6. Katherine Panageas (362)

More People

Years
  1. 2020 (199)
  2. 2019 (720)
  3. 2018 (691)
  4. 2017 (713)
  5. 2016 (634)
  6. 2015 (675)

More Years

Publications
  1. Journal of Clinical Oncology (860)
  2. Blood (310)
  3. Psycho-Oncology (274)
  4. Cancer (198)
  5. Cancer Research (191)
  6. Annals of Behavioral Medicine (175)

More Publications

Publishers
  1. American Society of Clinical Oncology (923)
  2. Springer (747)
  3. Elsevier Inc. (627)
  4. Elsevier Science, Inc. (602)
  5. American Association for Cancer Research (472)
  6. Oxford University Press (471)

More Publishers

Results (8167)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Does light chain suppression therapy improve cardiac structure and function in patients with advanced AL amyloidosis?
    Meeting Abstract

    Nahhas, O.; Lee Chuy, K.; Yang, J. C.; Landau, H.; Chen, C. L.; Yu, A. F.; Steingart, R. M.; Liu, J. E.
    Journal of the American College of Cardiology (2020)

    Fulltext@MSK | Save
  • Incremental value of GLS for classification of prognosis in patients with advanced light chain (AL) amyloidosis
    Meeting Abstract

    Nahhas, O.; Lee Chuy, K.; Yang, J. C.; Landau, H.; Drill, H.; Hassoun, H.; Chen, C. L.; Yu, A. F.; Steingart, R. M.; Liu, J. E.
    Journal of the American College of Cardiology (2020)

    Fulltext@MSK | Save
  • Cardiotoxicity surveillance and risk of heart failure during targeted-HER2 therapy: A case-control study
    Meeting Abstract

    Yu, A. F.; Moskowitz, C.; Lee Chuy, K.; Yang, J. C.; Liu, J. E.; Dang, C.; Oeffinger, K. C.; Steingart, R.
    Journal of the American College of Cardiology (2020)

    Fulltext@MSK | Save
  • The impact of cardiotoxicity and trastuzumab interruption on breast cancer outcomes
    Meeting Abstract

    Copeland-Halperin, R.; Al-Sadawi, M.; Patil, S.; Yadav, N.; Liu, J. E.; Dang, C.; Steingart, R.; Yu, A. F.
    Journal of the American College of Cardiology (2020)

    Fulltext@MSK | Save
  • An advanced practice provider initiative for delirium management in the ICU
    Journal Article

    Rebal, S.; Shirzadi, C.; Agatep, J.; Matsoukas, K.; Tan, K. S.; Seier, K.; Alici, Y.; Korc-Grodzicki, B.; Voigt, L.
    Journal of the Advanced Practitioner in Oncology (2020)

    Fulltext@MSK | Save
  • Cascading after peridiagnostic cancer genetic testing: An alternative to population-based screening
    Journal Article

    Offit, K.; Tkachuk, K. A.; Stadler, Z. K.; Walsh, M. F.; Diaz-Zabala, H.; Levin, J. D.; Steinsnyder, Z.; Ravichandran, V.; Sharaf, R. N.; Frey, M. K.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Prospective feasibility trial of a novel strategy of facilitated cascade genetic testing using telephone counseling
    Journal Article

    Frey, M. K.; Kahn, R. M.; Chapman-Davis, E.; Tubito, F.; Pires, M.; Christos, P.; Anderson, S.; Mukherjee, S.; Jordan, B.; Blank, S. V.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • The nutrition benefits participation gap: Barriers to uptake of SNAP and WIC among Latinx American immigrant families
    Journal Article

    Pelto, D. J.; Ocampo, A.; Garduño-Ortega, O.; Barraza López, C. T.; Macaluso, F.; Ramirez, J.; González, J.; Gany, F.
    Journal of Community Health (2020)

    Fulltext@MSK | Save
  • Impact of the 2018 American Society of Clinical Oncology/College of American Pathologists HER2 guideline updates on HER2 assessment in breast cancer with equivocal HER2 immunohistochemistry results with focus on cases with HER2/CEP17 ratio <2.0 and average HER2 copy number ≤4.0 and <6.0
    Journal Article

    Hoda, R. S.; Brogi, E.; Xu, J.; Ventura, K.; Ross, D. S.; Dang, C.; Robson, M.; Norton, L.; Morrow, M.; Wen, H. Y.
    Archives of Pathology & Laboratory Medicine (2020)

    Fulltext@MSK | Save
  • In memoriam: Marguerite S. Lederberg, MD (1937-2020)
    Journal Article

    Breitbart, W.
    Palliative and Supportive Care (2020)

    Fulltext@MSK | Save